» Articles » PMID: 8379811

Type Selective Inhibition of Microbial Fatty Acid Synthases by Thiolactomycin

Overview
Journal Arch Microbiol
Specialty Microbiology
Date 1993 Jan 1
PMID 8379811
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The antibiotic, thiolactomycin, is known to selectively inhibit the Type II straight-chain fatty acid synthase (monofunctional enzyme system, e.g. Escherichia coli enzyme) but not Type I straight-chain fatty acid synthase (multifunctional enzyme system, e.g. Saccharomyces cerevisiae enzyme). We have studied the effect of thiolactomycin on the branched-chain fatty acid synthases from Bacillus subtilis, Bacillus cereus, and Bacillus insolitus. Fatty acid synthase from all three Bacilli was not inhibited or only slightly inhibited by thiolactomycin. E. coli synthase, as expected, was strongly inhibited by thiolactomycin. Branched-chain fatty acid synthase from Bacillus species is a monofunctional enzyme system but, unlike Type II E. coli synthase, it is largely insensitive to thiolactomycin.

Citing Articles

Minimization of the Thiolactomycin Biosynthetic Pathway Reveals that the Cytochrome P450 Enzyme TlmF Is Required for Five-Membered Thiolactone Ring Formation.

Tang X, Li J, Moore B Chembiochem. 2017; 18(12):1072-1076.

PMID: 28393452 PMC: 5574029. DOI: 10.1002/cbic.201700090.


Response of Bacillus subtilis to cerulenin and acquisition of resistance.

Schujman G, Choi K, Altabe S, Rock C, de Mendoza D J Bacteriol. 2001; 183(10):3032-40.

PMID: 11325930 PMC: 95202. DOI: 10.1128/JB.183.10.3032-3040.2001.


Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems.

Schweizer H Antimicrob Agents Chemother. 1998; 42(2):394-8.

PMID: 9527792 PMC: 105420. DOI: 10.1128/AAC.42.2.394.


In vivo and in vitro effects of thiolactomycin on fatty acid biosynthesis in Streptomyces collinus.

WALLACE K, Lobo S, Han L, McArthur H, Reynolds K J Bacteriol. 1997; 179(12):3884-91.

PMID: 9190803 PMC: 179196. DOI: 10.1128/jb.179.12.3884-3891.1997.

References
1.
Hayashi T, Yamamoto O, Sasaki H, Kawaguchi A, Okazaki H . Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli. Biochem Biophys Res Commun. 1983; 115(3):1108-13. DOI: 10.1016/s0006-291x(83)80050-3. View

2.
ALBERTS A, Bell R, VAGELOS P . Acyl carrier protein. XV. Studies of -ketoacyl-acyl carrier protein synthetase. J Biol Chem. 1972; 247(10):3190-8. View

3.
Jackowski S, Murphy C, Cronan Jr J, Rock C . Acetoacetyl-acyl carrier protein synthase. A target for the antibiotic thiolactomycin. J Biol Chem. 1989; 264(13):7624-9. View

4.
Kaneda T . Iso- and anteiso-fatty acids in bacteria: biosynthesis, function, and taxonomic significance. Microbiol Rev. 1991; 55(2):288-302. PMC: 372815. DOI: 10.1128/mr.55.2.288-302.1991. View

5.
Jensen S, Westlake D, Wolfe S . Cyclization of delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine to penicillins by cell-free extracts of Streptomyces clavuligerus. J Antibiot (Tokyo). 1982; 35(4):483-90. DOI: 10.7164/antibiotics.35.483. View